M.‐P. Audrézet

1.6k total citations
26 papers, 700 citations indexed

About

M.‐P. Audrézet is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Surgery. According to data from OpenAlex, M.‐P. Audrézet has authored 26 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 6 papers in Genetics and 4 papers in Surgery. Recurrent topics in M.‐P. Audrézet's work include Cystic Fibrosis Research Advances (18 papers), Neonatal Respiratory Health Research (11 papers) and Tracheal and airway disorders (7 papers). M.‐P. Audrézet is often cited by papers focused on Cystic Fibrosis Research Advances (18 papers), Neonatal Respiratory Health Research (11 papers) and Tracheal and airway disorders (7 papers). M.‐P. Audrézet collaborates with scholars based in France, Russia and United Kingdom. M.‐P. Audrézet's co-authors include Claude Férec, I. Quéré, Bernard Mercier, C. Verlingue, Odile Raguénès, H. Guillermit, Cédric Le Maréchal, Jian‐Min Chen, Emmanuelle Masson and D.N. Cooper and has published in prestigious journals such as Nature Genetics, PLoS ONE and Journal of Medical Genetics.

In The Last Decade

M.‐P. Audrézet

26 papers receiving 679 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.‐P. Audrézet France 12 379 223 167 89 88 26 700
Pierfranco Pignatti Italy 10 232 0.6× 67 0.3× 26 0.2× 74 0.8× 65 0.7× 17 416
Hila Barak United States 11 187 0.5× 64 0.3× 57 0.3× 87 1.0× 389 4.4× 21 521
Agnieszka Sobczyńska‐Tomaszewska Poland 9 95 0.3× 93 0.4× 50 0.3× 53 0.6× 86 1.0× 37 318
Shinichiro Kitada Japan 12 88 0.2× 139 0.6× 56 0.3× 25 0.3× 79 0.9× 24 515
Shiyu Tong China 13 128 0.3× 104 0.5× 76 0.5× 7 0.1× 138 1.6× 29 383
D. Hunter Best United States 11 238 0.6× 108 0.5× 26 0.2× 113 1.3× 163 1.9× 25 515
А. Г. Никитин Russia 11 82 0.2× 42 0.2× 40 0.2× 49 0.6× 154 1.8× 55 397
Ikechukwu I. Ekekezie United States 14 451 1.2× 322 1.4× 78 0.5× 29 0.3× 97 1.1× 23 609
Dorit Omer Israel 12 208 0.5× 112 0.5× 64 0.4× 48 0.5× 484 5.5× 21 587
Anita I. R. Spanjer Netherlands 8 230 0.6× 67 0.3× 31 0.2× 41 0.5× 173 2.0× 10 426

Countries citing papers authored by M.‐P. Audrézet

Since Specialization
Citations

This map shows the geographic impact of M.‐P. Audrézet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.‐P. Audrézet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.‐P. Audrézet more than expected).

Fields of papers citing papers by M.‐P. Audrézet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.‐P. Audrézet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.‐P. Audrézet. The network helps show where M.‐P. Audrézet may publish in the future.

Co-authorship network of co-authors of M.‐P. Audrézet

This figure shows the co-authorship network connecting the top 25 collaborators of M.‐P. Audrézet. A scholar is included among the top collaborators of M.‐P. Audrézet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.‐P. Audrézet. M.‐P. Audrézet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Audrézet, M.‐P., Caroline Raynal, Isabelle Sermet‐Gaudelus, et al.. (2020). Penetrance is a critical parameter for assessing the disease liability of CFTR variants. Journal of Cystic Fibrosis. 19(6). 949–954. 11 indexed citations
2.
Laudus, Nele, M.‐P. Audrézet, Emmanuelle Girodon, et al.. (2020). Laboratory reporting on the clinical spectrum of CFTR p.Arg117His: Still room for improvement. Journal of Cystic Fibrosis. 19(6). 969–974. 1 indexed citations
3.
Girodon, E., Caroline Raynal, M.‐P. Audrézet, et al.. (2019). P019 Variants in the CFTR gene: a predisposition factor to aquagenic palmoplantar keratoderma. Journal of Cystic Fibrosis. 18. S62–S62. 1 indexed citations
4.
Sermet‐Gaudelus, Isabelle, J. Brouard, M.‐P. Audrézet, et al.. (2017). Recommandations pour la prise en charge et le suivi des nourrissons pour lesquels un diagnostic de mucoviscidose n’a pu être conclu après dépistage néonatal. Archives de Pédiatrie. 24(4). 401–414. 2 indexed citations
5.
Sermet‐Gaudelus, Isabelle, J. Brouard, M.‐P. Audrézet, et al.. (2017). Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening. Archives de Pédiatrie. 24(12). e1–e14. 21 indexed citations
6.
Miné, Manuèle, Tibor Kovács, Dániel Bereczki, et al.. (2014). COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy. Journal of Neurology. 261(3). 500–503. 31 indexed citations
7.
Masson, Emmanuelle, Jian‐Min Chen, M.‐P. Audrézet, D.N. Cooper, & Claude Férec. (2013). A Conservative Assessment of the Major Genetic Causes of Idiopathic Chronic Pancreatitis: Data from a Comprehensive Analysis of PRSS1, SPINK1, CTRC and CFTR Genes in 253 Young French Patients. PLoS ONE. 8(8). e73522–e73522. 72 indexed citations
8.
Audrézet, M.‐P., et al.. (2012). Autosomal dominant polycystic kidney disease in University Clinic of Nephrology and Haemodialysis of Cotonou: clinical and genetical findings.. PubMed. 23(4). 435–45. 5 indexed citations
9.
Duguépéroux, I., Virginie Scotet, M.‐P. Audrézet, et al.. (2010). Non-visualization of the gallbladder: a major risk of cystic fibrosis when associated with echogenic bowel. Journal of Cystic Fibrosis. 9. S11–S11. 1 indexed citations
10.
Roussey, M., M.‐P. Audrézet, Martine Blayau, et al.. (2005). Dépistage néonatal de la mucoviscidose : problèmes diagnostiques et aspects éthiques des formes frontières. Archives de Pédiatrie. 12(6). 650–653. 3 indexed citations
11.
Férec, Claude, Cédric Le Maréchal, M.‐P. Audrézet, et al.. (2004). Analysis of genomic CFTR DNA. Journal of Cystic Fibrosis. 3. 7–10. 7 indexed citations
12.
Audrézet, M.‐P., et al.. (2004). Association du polymorphisme glu27gln avec la dermatite atopique intrinsèque. Annales de Dermatologie et de Vénéréologie. 131(12). 1129–1129. 1 indexed citations
14.
Scotet, Virginie, Marc De Braekeleer, M.‐P. Audrézet, et al.. (2001). Prevalence of CFTR mutations in hypertrypsinaemia detected through neonatal screening for cystic fibrosis. Clinical Genetics. 59(1). 42–47. 28 indexed citations
15.
Férec, Claude, C. Verlingue, Philippe Parent, et al.. (1995). Neonatal screening for cystic fibrosis: result of a pilot study using both immunoreactive trypsinogen and cystic fibrosis gene mutation analyses. Human Genetics. 96(5). 542–548. 32 indexed citations
16.
Verlingue, C., Bernard Mercier, E. K. Ginter, et al.. (1995). Complete screening of mutations in the coding sequence of the CFTR gene in a sample of CF patients from Russia: Identification of three novel alleles. Human Mutation. 5(3). 205–209. 7 indexed citations
17.
Jehanne, M, M.‐P. Audrézet, Bernard Mercier, et al.. (1994). Association of 1078 del T cystic fibrosis mutation with severe disease.. Journal of Medical Genetics. 31(2). 159–161. 7 indexed citations
18.
Audrézet, M.‐P., Bruno Costes, N. Ghanem, et al.. (1993). Screening for cystic fibrosis in dried blood spots of newborns. Molecular and Cellular Probes. 7(6). 497–502. 25 indexed citations
19.
Lissens, Willy, et al.. (1993). Detection of more than 94% cystic fibrosis mutations in a sample of belgian population and identification of four novel mutations. Human Mutation. 2(1). 16–20. 23 indexed citations
20.
Férec, Claude, M.‐P. Audrézet, Bernard Mercier, et al.. (1992). Detection of over 98% cystic fibrosis mutations in a Celtic population. Nature Genetics. 1(3). 188–191. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026